المؤلفون: Pastò B; Department of Medicine (DMED), University of Udine, Udine 33100, Italy; Department of Medical Oncology, Centro di Riferimento Oncologico di Aviano (CRO), IRCCS, Aviano 33081, Italy., Buzzatti G; Department of Medical Oncology, U.O. Clinica di Oncologia Medica, IRCCS Ospedale Policlinico San Martino, Genova 16132, Italy., Schettino C; Clinical Trials Unit, Istituto Nazionale Tumori, IRCCS, Fondazione G. Pascale, Napoli 80131, Italy., Malapelle U; Department of Public Health, University of Naples Federico II, Napoli 80131, Italy., Bergamini A; Faculty of Medicine and Surgery, Vita-Salute San Raffaele University, Milano 20132, Italy; Unit of Obstetrics and Gynaecology, IRCCS San Raffaele Scientific Institute, Milano 20132, Italy., De Angelis C; Oncology Unit - Department of Clinical Medicine and Surgery, University of Naples Federico II, Napoli 80131, Italy., Musacchio L; Department of Women and Child Health, Division of Gynaecologic Oncology, Fondazione Policlinico Universitario 'A. Gemelli' IRCCS, Roma 00168, Italy., Dieci MV; Department of Surgery, Oncology and Gastroenterology, University of Padova, Padova 35122, Italy; Oncology 2, Veneto Institute of Oncology IOV-IRCCS, Padova 35128, Italy., Kuhn E; Department of Biomedical, Surgical and Dental Sciences, University of Milan, Milano 20122, Italy; Pathology Unit, Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico, Milano 20122, Italy., Lambertini M; Department of Medical Oncology, U.O. Clinica di Oncologia Medica, IRCCS Ospedale Policlinico San Martino, Genova 16132, Italy; Department of Internal Medicine and Medical Specialties (DiMI), School of Medicine, University of Genova, Genova 16132, Italy., Passarelli A; Department of Urology and Gynaecology, Istituto Nazionale Tumori IRCCS 'Fondazione G. Pascale', Napoli 80131, Italy., Toss A; Department of Oncology and Hematology, Azienda Ospedaliero-Universitaria di Modena, Modena 41124, Italy; Department of Medical and Surgical Sciences, University of Modena and Reggio Emilia, Modena 41124, Italy., Farolfi A; Department of Medical Oncology, IRCCS Istituto Romagnolo per lo Studio dei Tumori (IRST) 'Dino Amadori', Meldola 47014, Italy., Roncato R; Department of Medicine (DMED), University of Udine, Udine 33100, Italy; Experimental and Clinical Pharmacology Unit, Centro di Riferimento Oncologico di Aviano (CRO) IRCCS, Aviano 33081, Italy., Capoluongo E; Department of Molecular Medicine and Medical Biotechnologies, University of Naples Federico II, Napoli 80131, Italy; Clinical Pathology Unit, Azienda Ospedaliera San Giovanni Addolorata, Roma 00184, Italy., Vida R; Department of Medicine (DMED), University of Udine, Udine 33100, Italy; Department of Medical Oncology, Centro di Riferimento Oncologico di Aviano (CRO), IRCCS, Aviano 33081, Italy., Pignata S; Department of Urology and Gynaecology, Istituto Nazionale Tumori IRCCS 'Fondazione G. Pascale', Napoli 80131, Italy., Callari M; Fondazione Michelangelo, Milano 20121, Italy., Baldassarre G; Molecular Oncology Unit, Centro di Riferimento Oncologico di Aviano (CRO) IRCCS, Aviano 33081, Italy., Bartoletti M; Department of Medical Oncology, Centro di Riferimento Oncologico di Aviano (CRO), IRCCS, Aviano 33081, Italy., Gerratana L; Department of Medicine (DMED), University of Udine, Udine 33100, Italy; Department of Medical Oncology, Centro di Riferimento Oncologico di Aviano (CRO), IRCCS, Aviano 33081, Italy. Electronic address: lorenzo.gerratana@cro.it., Puglisi F; Department of Medicine (DMED), University of Udine, Udine 33100, Italy; Department of Medical Oncology, Centro di Riferimento Oncologico di Aviano (CRO), IRCCS, Aviano 33081, Italy.

المصدر: Critical reviews in oncology/hematology [Crit Rev Oncol Hematol] 2024 Jul; Vol. 199, pp. 104379. Date of Electronic Publication: 2024 May 07.

نوع المنشور: Journal Article; Review

بيانات الدورية: Publisher: Elsevier Scientific Publishers Country of Publication: Netherlands NLM ID: 8916049 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1879-0461 (Electronic) Linking ISSN: 10408428 NLM ISO Abbreviation: Crit Rev Oncol Hematol Subsets: MEDLINE

مواضيع طبية MeSH: Neoplasms*/genetics , Neoplasms*/therapy , Neoplasms*/diagnosis , Precision Medicine*/methods, Humans ; Molecular Targeted Therapy/methods ; Critical Pathways

المؤلفون: Canino F; Division of Medical Oncology, Department of Medical and Surgical Sciences for Children and Adults, University Hospital of Modena, Largo del Pozzo 71, Modena, 41124, Italy. fabio.canino@unimore.it., Barbolini M; Division of Medical Oncology, Department of Oncology and Hematology, University Hospital of Modena, Modena, Italy., De Giorgi U; Department of Medical Oncology, IRCCS Istituto Romagnolo per lo Studio dei Tumori (IRST) 'Dino Amadori', Meldola, Italy., Fontana T; Istituto di Ricovero e Cura a Carattere Scientifico (IRCCS) Azienda Ospedaliero-Universitaria di Bologna, Bologna, Italy., Gaspari V; Department of Medical Oncology, Infermi Hospital, AUSL della Romagna, Rimini, Italy., Gianni C; Department of Medical Oncology, IRCCS Istituto Romagnolo per lo Studio dei Tumori (IRST) 'Dino Amadori', Meldola, Italy., Gianni L; Department of Medical Oncology, Infermi Hospital, AUSL della Romagna, Rimini, Italy., Maestri A; Department of Medical Oncology, AUSL di Bologna, Bologna, Italy., Minichillo S; Department of Medical Oncology, AUSL di Bologna, Bologna, Italy., Moscetti L; Division of Medical Oncology, Department of Oncology and Hematology, University Hospital of Modena, Modena, Italy., Mura A; Department of Medical Oncology, AUSL di Bologna, Bologna, Italy., Nicoletti SVL; Department of Medical Oncology, Infermi Hospital, AUSL della Romagna, Rimini, Italy., Omarini C; Division of Medical Oncology, Department of Oncology and Hematology, University Hospital of Modena, Modena, Italy., Pagani R; Istituto di Ricovero e Cura a Carattere Scientifico (IRCCS) Azienda Ospedaliero-Universitaria di Bologna, Bologna, Italy., Sarti S; Department of Medical Oncology, IRCCS Istituto Romagnolo per lo Studio dei Tumori (IRST) 'Dino Amadori', Meldola, Italy., Toss A; Division of Medical Oncology, Department of Medical and Surgical Sciences for Children and Adults, University Hospital of Modena, Largo del Pozzo 71, Modena, 41124, Italy.; Division of Medical Oncology, Department of Oncology and Hematology, University Hospital of Modena, Modena, Italy., Zamagni C; Istituto di Ricovero e Cura a Carattere Scientifico (IRCCS) Azienda Ospedaliero-Universitaria di Bologna, Bologna, Italy., Cuoghi Costantini R; Unit of Clinical Statistics, University Hospital of Modena, Modena, Italy., Caggia F; Division of Medical Oncology, Department of Medical and Surgical Sciences for Children and Adults, University Hospital of Modena, Largo del Pozzo 71, Modena, 41124, Italy., Antonelli G; Division of Medical Oncology, Department of Medical and Surgical Sciences for Children and Adults, University Hospital of Modena, Largo del Pozzo 71, Modena, 41124, Italy., Baglio F; Division of Medical Oncology, Department of Medical and Surgical Sciences for Children and Adults, University Hospital of Modena, Largo del Pozzo 71, Modena, 41124, Italy., Belluzzi L; Division of Medical Oncology, Department of Medical and Surgical Sciences for Children and Adults, University Hospital of Modena, Largo del Pozzo 71, Modena, 41124, Italy., Martinelli G; Division of Medical Oncology, Department of Medical and Surgical Sciences for Children and Adults, University Hospital of Modena, Largo del Pozzo 71, Modena, 41124, Italy., Natalizio S; Division of Medical Oncology, Department of Medical and Surgical Sciences for Children and Adults, University Hospital of Modena, Largo del Pozzo 71, Modena, 41124, Italy., Ponzoni O; Division of Medical Oncology, Department of Medical and Surgical Sciences for Children and Adults, University Hospital of Modena, Largo del Pozzo 71, Modena, 41124, Italy., Dominici M; Division of Medical Oncology, Department of Medical and Surgical Sciences for Children and Adults, University Hospital of Modena, Largo del Pozzo 71, Modena, 41124, Italy.; Division of Medical Oncology, Department of Oncology and Hematology, University Hospital of Modena, Modena, Italy., Piacentini F; Division of Medical Oncology, Department of Medical and Surgical Sciences for Children and Adults, University Hospital of Modena, Largo del Pozzo 71, Modena, 41124, Italy.; Division of Medical Oncology, Department of Oncology and Hematology, University Hospital of Modena, Modena, Italy.

المصدر: BMC cancer [BMC Cancer] 2024 Jun 15; Vol. 24 (1), pp. 735. Date of Electronic Publication: 2024 Jun 15.

نوع المنشور: Journal Article; Multicenter Study

بيانات الدورية: Publisher: BioMed Central Country of Publication: England NLM ID: 100967800 Publication Model: Electronic Cited Medium: Internet ISSN: 1471-2407 (Electronic) Linking ISSN: 14712407 NLM ISO Abbreviation: BMC Cancer Subsets: MEDLINE

مواضيع طبية MeSH: Breast Neoplasms*/drug therapy , Breast Neoplasms*/pathology , Breast Neoplasms*/metabolism , Trastuzumab*/administration & dosage , Trastuzumab*/adverse effects , Trastuzumab*/therapeutic use , Neoadjuvant Therapy*/methods , Antineoplastic Combined Chemotherapy Protocols*/therapeutic use , Antineoplastic Combined Chemotherapy Protocols*/adverse effects , Antibodies, Monoclonal, Humanized*/adverse effects , Antibodies, Monoclonal, Humanized*/administration & dosage , Antibodies, Monoclonal, Humanized*/therapeutic use , Receptor, ErbB-2*/metabolism, Humans ; Female ; Middle Aged ; Retrospective Studies ; Adult ; Aged ; Treatment Outcome ; Neoplasm Staging

المؤلفون: Schettini F; Translational Genomics and Targeted Therapies in Solid Tumors group, August Pi i Sunyer Biomedical Research Institute (IDIBAPS), Barcelona, Spain.; Department of Medical Oncology, Hospital Clinic of Barcelona, Barcelona, Spain.; Department of Medicine and Health Sciences, University of Barcelona, Barcelona, Spain., Blondeaux E; U.O. Epidemiologia Clinica, IRCCS Ospedale Policlinico San Martino, Genova, Italy., Molinelli C; Department of Internal Medicine and Medical Specialties (DiMI), School of Medicine, University of Genova, Genova, Italy.; Department of Medical Oncology, U.O. Clinica di Oncologia Medica, IRCCS Ospedale Policlinico San Martino, Genova, Italy., Bas R; Department of Medical Oncology, Universite Paris Cité, Institut Curie, Paris, France., Kim HJ; Division of Breast Surgery, Department of Surgery, Asan Medical Center, University of Ulsan College of Medicine, Seoul, South Korea., Di Meglio A; Cancer Survivorship Group, INSERM U981, Gustave Roussy, Villejuif, France., Bernstein Molho R; Susanne Levy Gertner Oncogenetics Unit, The Danek Gertner Institute of Human Genetics, Chaim Sheba Medical Center affiliated to Tel Aviv University, Tel Hashomer, Israel., Linn SC; Department of Medical Oncology, Netherlands Cancer Institute (NKI), Amsterdam, The Netherlands.; Department of Pathology, University Medical Center Utrecht, Utrecht, The Netherlands., Pogoda K; Department of Breast Cancer and Reconstructive Surgery, Maria Sklodowska-Curie National Research Institute of Oncology, Warsaw, Poland., Carrasco E; Hereditary Cancer Genetics Unit, Medical oncology Department, Vall d´Hebron University Hospital, Vall d´Hebron Institute of Oncology (VHIO), Barcelona, Spain., Punie K; Department of General Medical Oncology and Multidisciplinary Breast Center, Leuven Cancer Institute, University Hospitals Leuven, Leuven, Belgium., Agostinetto E; Institut Jules Bordet and l'Université Libre de Bruxelles (U.L.B.), Hôpital Universitaire de Bruxelles (HUB), Brussels, Belgium., Lopetegui-Lia N; Department of Medical Oncology, Cleveland Clinic Taussig Cancer Institute, Cleveland, Ohio, USA., Phillips KA; Department of Medical Oncology, Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia.; Sir Peter MacCallum Department of Oncology, The University of Melbourne, Melbourne, Victoria, Australia.; Centre for Epidemiology and Biostatistics, School of Population and Global Health, The University of Melbourne, Melbourne, Victoria, Australia., Toss A; Department of Oncology and Haematology, Azienda Ospedaliero-Universitaria di Modena, Modena, Italy.; Division of Oncology, Department of Medical and Surgical Sciences, University of Modena and Reggio Emilia, Modena, Italy., Rousset-Jablonski C; Department of Surgery, Leon Berard Cancer Center, Lyon, France.; Unité INSERM U1290, Université Claude Bernard Lyon 1, Lyon, France.; Hopital Femme Mère Enfant, Hospice civils de Lyon, Bron, France., Acheritogaray M; Department of Gynecology, Cote Basque Hospital Center, Bayonne, France., Ferrari A; Hereditary Breast and Ovarian Cancer (HBOC) Unit and General Surgery 3 - Senology, Breast Cancer Center, Fondazione IRCCS Policlinico San Matteo, Pavia, Italy.; University of Pavia, Pavia, Italy., Paluch-Shimon S; Sharett institute of oncology, Hadassah University Hospital & Faculty of Medicine, Hebrew University, Jerusalem, Israel., Fruscio R; UO Gynecology, Department of Medicine and Surgery, University of Milan-Bicocca, IRCCS San Gerardo dei Tintori, Monza, Italy., Cui W; Department of Medical Oncology, Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia.; Sir Peter MacCallum Department of Oncology, The University of Melbourne, Melbourne, Victoria, Australia., Wong SM; Stroll Cancer Prevention Centre, Jewish General Hospital, and McGill University Medical School, Montreal, Quebec, Canada., Vernieri C; Medical Oncology Department, Breast Unit, Fondazione IRCCS Istituto Nazionale dei Tumori, Milano, Italy.; Oncology and Hematology-Oncology Department, University of Milan, Milano, Italy., Dieci MV; Dipartimento di Scienze Chirurgiche, Oncologiche e Gastroenterologiche, Università di Padova, Padova, Italy.; Oncologia 2, Istituto Oncologico Veneto IRCCS, Padova, Italy., Matikas A; Department of Oncology/Pathology, Karolinska Institute and Breast Center, Karolinska University Hospital, Stockholm, Sweden., Rozenblit M; Medical Oncology, Yale University, New Haven, Connecticut, USA., Villarreal-Garza C; Breast Cancer Center, Hospital Zambrano Hellion - TecSalud, Tecnologico de Monterrey, Monterrey, Mexico., De Marchis L; Division of Medical Oncology, Department of Radiological, Oncological and Pathological Sciences, Sapienza University of Rome, Rome, Italy.; Medical Oncology Department of Hematology, Oncology, Dermatology, Umberto 1 University Hospital, Rome, Italy., Puglisi F; Department of Medical Oncology, Centro di Riferimento Oncologico di Aviano (CRO) IRCCS, Aviano, Italy.; Department of Medicine, University of Udine, Udine, Italy., Vasconcelos de Matos L; Breast Cancer Unit, Champalimaud Clinical Center, Champalimaud Foundation, Lisbon, Portugal., Mariño M; Hospital Universitari Son Espases Palma, Palma, Spain., Teixeira L; Department of Senology, Université Paris Cité, Assistance Publique-Hôpitaux de Paris, Saint Louis University Hospital, Paris, France., Graffeo R; Oncology Institute of Southern Switzerland, EOC-IOSI, Bellinzona, Switzerland., Rognone A; Department of Oncology, IRCCS Ospedale San Raffaele, Milano, Italy., Chirco A; Medical Oncology Unit, ASST Papa Giovanni XXIII, Bergamo, Italy., Antone N; Institute of Oncology 'Ion Chiricuta', Cluj-Napoca, Romania., Abdou Y; University of North Carolina - Lineberger Comprehensive Cancer Center, Chapel Hill, North Carolina, USA., Marhold M; Division of Oncology, Department of Medicine I, Medical University of Vienna, Vienna, Austria., Božović-Spasojević I; Institute for Oncology and Radiology of Serbia, University of Belgrade, Faculty of Medicine, Belgrade, Serbia., Cortés Salgado A; Medical Oncology Department, Hospital Universitario Ramón y Cajal, Madrid, Spain., Carmisciano L; Department of Clinical and Experimental Medicine, University of Pisa, Pisa, Italy., Bruzzone M; U.O. Epidemiologia Clinica, IRCCS Ospedale Policlinico San Martino, Genova, Italy., Curigliano G; Early Drug Development for Innovative Therapies Division, IRCCS European Institute of Oncology (IEO), Milan, Italy.; Department of Oncology and Hemato-Oncology, University of Milan, Milan, Italy., Prat A; Translational Genomics and Targeted Therapies in Solid Tumors group, August Pi i Sunyer Biomedical Research Institute (IDIBAPS), Barcelona, Spain.; Department of Medicine and Health Sciences, University of Barcelona, Barcelona, Spain.; Institute of Cancer and Blood Disorders, Hospital Clinic of Barcelona, Barcelona, Spain.; Reveal Genomics, Barcelona, Spain.; Institute of Oncology (IOB)-Hospital Quirón Salud, Barcelona, Spain., Lambertini M; Department of Internal Medicine and Medical Specialties (DiMI), School of Medicine, University of Genova, Genova, Italy.; Department of Medical Oncology, U.O. Clinica di Oncologia Medica, IRCCS Ospedale Policlinico San Martino, Genova, Italy.

المصدر: Cancer [Cancer] 2024 May 16. Date of Electronic Publication: 2024 May 16.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: Wiley Country of Publication: United States NLM ID: 0374236 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1097-0142 (Electronic) Linking ISSN: 0008543X NLM ISO Abbreviation: Cancer Subsets: MEDLINE

المؤلفون: Morganti S; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts.; Harvard Medical School, Boston, Massachusetts.; Broad Institute of MIT and Harvard, Cambridge, Massachusetts., Marra A; European Institute of Oncology IRCCS, Milan, Italy., De Angelis C; Department of Clinical Medicine and Surgery, University Federico II, Naples, Italy.; Laster and Sue Smith Breast Center, Baylor College of Medicine, Houston, Texas., Toss A; Department of Oncology and Hematology, Azienda Ospedaliero-Universitaria di Modena, Modena, Italy.; Department of Medical and Surgical Sciences, University of Modena and Reggio Emilia, Modena, Italy., Licata L; Department of Medical Oncology, San Raffaele Hospital, Milan, Italy.; School of Medicine and Surgery, Vita-Salute San Raffaele University, Milan, Italy., Giugliano F; European Institute of Oncology IRCCS, Milan, Italy.; Department of Oncology and Hemato-Oncology, University of Milan, Milan, Italy.; INSERM U981-Molecular Predictors and New Targets in Oncology, PRISM Center for Precision Medicine, Gustave Roussy, Villejuif, France., Taurelli Salimbeni B; European Institute of Oncology IRCCS, Milan, Italy., Berton Giachetti PPM; European Institute of Oncology IRCCS, Milan, Italy.; Department of Oncology and Hemato-Oncology, University of Milan, Milan, Italy., Esposito A; Department of Oncology and Hemato-Oncology, University of Milan, Milan, Italy., Giordano A; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts.; Harvard Medical School, Boston, Massachusetts., Bianchini G; Department of Medical Oncology, San Raffaele Hospital, Milan, Italy.; School of Medicine and Surgery, Vita-Salute San Raffaele University, Milan, Italy., Garber JE; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts.; Harvard Medical School, Boston, Massachusetts., Curigliano G; European Institute of Oncology IRCCS, Milan, Italy.; Department of Oncology and Hemato-Oncology, University of Milan, Milan, Italy., Lynce F; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts.; Harvard Medical School, Boston, Massachusetts., Criscitiello C; European Institute of Oncology IRCCS, Milan, Italy.; Department of Oncology and Hemato-Oncology, University of Milan, Milan, Italy.

المصدر: JAMA oncology [JAMA Oncol] 2024 May 01; Vol. 10 (5), pp. 658-670.

نوع المنشور: Journal Article; Review

بيانات الدورية: Publisher: American Medical Association Country of Publication: United States NLM ID: 101652861 Publication Model: Print Cited Medium: Internet ISSN: 2374-2445 (Electronic) Linking ISSN: 23742437 NLM ISO Abbreviation: JAMA Oncol Subsets: MEDLINE

مواضيع طبية MeSH: Poly(ADP-ribose) Polymerase Inhibitors*/therapeutic use , Breast Neoplasms*/drug therapy , Breast Neoplasms*/genetics , Breast Neoplasms*/pathology , Drug Resistance, Neoplasm*, Humans ; Female ; BRCA1 Protein/genetics ; BRCA2 Protein/genetics ; Antineoplastic Agents/therapeutic use ; Antineoplastic Agents/adverse effects ; Poly (ADP-Ribose) Polymerase-1/antagonists & inhibitors ; Treatment Outcome

المؤلفون: D'Agostino E; Department of Oncology and Hematology, Azienda Ospedaliero-Universitaria di Modena, 41124 Modena, Italy., Mastrodomenico L; Department of Oncology and Hematology, Azienda Ospedaliero-Universitaria di Modena, 41124 Modena, Italy., Ponzoni O; Department of Oncology and Hematology, Azienda Ospedaliero-Universitaria di Modena, 41124 Modena, Italy., Baldessari C; Department of Oncology and Hematology, Azienda Ospedaliero-Universitaria di Modena, 41124 Modena, Italy., Piombino C; Department of Oncology and Hematology, Azienda Ospedaliero-Universitaria di Modena, 41124 Modena, Italy., Pipitone S; Department of Medical and Surgical Sciences, University of Modena and Reggio Emilia, Modena, Italy., Giuseppa Vitale M; Department of Oncology and Hematology, Azienda Ospedaliero-Universitaria di Modena, 41124 Modena, Italy., Sabbatini R; Department of Oncology and Hematology, Azienda Ospedaliero-Universitaria di Modena, 41124 Modena, Italy. Electronic address: sabbrob@unimore.it., Dominici M; Department of Oncology and Hematology, Azienda Ospedaliero-Universitaria di Modena, 41124 Modena, Italy; Department of Medical and Surgical Sciences, University of Modena and Reggio Emilia, Modena, Italy., Toss A; Department of Oncology and Hematology, Azienda Ospedaliero-Universitaria di Modena, 41124 Modena, Italy; Department of Medical and Surgical Sciences, University of Modena and Reggio Emilia, Modena, Italy. Electronic address: angela.toss@unimore.it.

المصدر: Cancer treatment reviews [Cancer Treat Rev] 2024 May; Vol. 126, pp. 102723. Date of Electronic Publication: 2024 Mar 27.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: Elsevier Country of Publication: Netherlands NLM ID: 7502030 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1532-1967 (Electronic) Linking ISSN: 03057372 NLM ISO Abbreviation: Cancer Treat Rev Subsets: MEDLINE

مواضيع طبية MeSH: Endometrial Neoplasms*/genetics , Endometrial Neoplasms*/therapy , Endometrial Neoplasms*/pathology, Female ; Humans ; Biomarkers, Tumor/genetics ; Colorectal Neoplasms, Hereditary Nonpolyposis/genetics ; Colorectal Neoplasms, Hereditary Nonpolyposis/therapy ; Colorectal Neoplasms, Hereditary Nonpolyposis/diagnosis ; Prognosis

المؤلفون: Canino F; Division of Medical Oncology, Department of Medical and Surgical Sciences for Children and Adults, University Hospital of Modena, 41124 Modena, Italy.; Gruppo Oncologico Italiano di Ricerca Clinica (GOIRC), 43126 Parma, Italy., Tornincasa A; Unità Operativa di Oncologia, ASL I dell'Umbria, 06012 Città di Castello, Italy., Bettelli S; Molecular Pathology and Predictive Medicine, Azienda Ospedaliero, Universitaria Policlinico di Modena, 41124 Modena, Italy., Manfredini S; Molecular Pathology and Predictive Medicine, Azienda Ospedaliero, Universitaria Policlinico di Modena, 41124 Modena, Italy., Barbolini M; Division of Medical Oncology, Department of Medical and Surgical Sciences for Children and Adults, University Hospital of Modena, 41124 Modena, Italy.; Gruppo Oncologico Italiano di Ricerca Clinica (GOIRC), 43126 Parma, Italy., Moscetti L; Gruppo Oncologico Italiano di Ricerca Clinica (GOIRC), 43126 Parma, Italy.; Division of Medical Oncology, Department of Oncology and Ematology, Azienda Ospedaliero, Universitaria Policlinico di Modena, 41124 Modena, Italy., Omarini C; Gruppo Oncologico Italiano di Ricerca Clinica (GOIRC), 43126 Parma, Italy.; Division of Medical Oncology, Department of Oncology and Ematology, Azienda Ospedaliero, Universitaria Policlinico di Modena, 41124 Modena, Italy., Toss A; Division of Medical Oncology, Department of Medical and Surgical Sciences for Children and Adults, University Hospital of Modena, 41124 Modena, Italy., Tamburrano F; Division of Medical Oncology, Department of Medical and Surgical Sciences for Children and Adults, University Hospital of Modena, 41124 Modena, Italy., Antonelli G; Division of Medical Oncology, Department of Medical and Surgical Sciences for Children and Adults, University Hospital of Modena, 41124 Modena, Italy., Baglio F; Division of Medical Oncology, Department of Medical and Surgical Sciences for Children and Adults, University Hospital of Modena, 41124 Modena, Italy., Belluzzi L; Division of Medical Oncology, Department of Medical and Surgical Sciences for Children and Adults, University Hospital of Modena, 41124 Modena, Italy., Martinelli G; Division of Medical Oncology, Department of Medical and Surgical Sciences for Children and Adults, University Hospital of Modena, 41124 Modena, Italy.; Gruppo Oncologico Italiano di Ricerca Clinica (GOIRC), 43126 Parma, Italy., Natalizio S; Division of Medical Oncology, Department of Medical and Surgical Sciences for Children and Adults, University Hospital of Modena, 41124 Modena, Italy., Ponzoni O; Division of Medical Oncology, Department of Medical and Surgical Sciences for Children and Adults, University Hospital of Modena, 41124 Modena, Italy., Dominici M; Division of Medical Oncology, Department of Medical and Surgical Sciences for Children and Adults, University Hospital of Modena, 41124 Modena, Italy., Piacentini F; Division of Medical Oncology, Department of Medical and Surgical Sciences for Children and Adults, University Hospital of Modena, 41124 Modena, Italy.; Gruppo Oncologico Italiano di Ricerca Clinica (GOIRC), 43126 Parma, Italy.

المصدر: International journal of molecular sciences [Int J Mol Sci] 2024 Feb 20; Vol. 25 (5). Date of Electronic Publication: 2024 Feb 20.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: MDPI Country of Publication: Switzerland NLM ID: 101092791 Publication Model: Electronic Cited Medium: Internet ISSN: 1422-0067 (Electronic) Linking ISSN: 14220067 NLM ISO Abbreviation: Int J Mol Sci Subsets: MEDLINE

مواضيع طبية MeSH: Breast Neoplasms*/pathology, Humans ; Middle Aged ; Female ; Biomarkers, Tumor/genetics ; Retrospective Studies ; High-Throughput Nucleotide Sequencing/methods ; Class I Phosphatidylinositol 3-Kinases/genetics

المؤلفون: Lambertini M; Department of Internal Medicine and Medical Specialties (DIMI), School of Medicine, University of Genova, Genova, Italy.; Department of Medical Oncology, U. O. Clinica di Oncologia Medica, IRCCS Ospedale Policlinico San Martino, Genova, Italy., Blondeaux E; U. O. Epidemiologia Clinica, IRCCS Ospedale Policlinico San Martino, Genova, Italy., Agostinetto E; Breast Medical Oncology Clinic, Institut Jules Bordet, Université Libre de Bruxelles (ULB), Hôpital Universitaire de Bruxelles (HUB), Brussels, Belgium., Hamy AS; Department of Medical Oncology, Universite Paris Cité, Institut Curie, Paris, France., Kim HJ; Division of Breast Surgery, Department of Surgery, Asan Medical Center, University of Ulsan College of Medicine, Seoul, South Korea., Di Meglio A; Cancer Survivorship Program-Molecular Predicitors and New Targets in Oncology, INSERM Unit 981, Gustave Roussy, Villejuif, France., Bernstein Molho R; Susanne Levy Gertner Oncogenetics Unit, Danek Gertner Institute of Human Genetics, Chaim Sheba Medical Center Affiliated to Tel Aviv University, Tel Hashomer, Israel., Hilbers F; Department of Molecular Pathology, Netherlands Cancer Institute, Amsterdam, the Netherlands., Pogoda K; Department of Breast Cancer and Reconstructive Surgery, Maria Sklodowska-Curie National Research Institute of Oncology, Warsaw, Poland., Carrasco E; Hereditary Cancer Genetics Unit, Medical Oncology Department, Vall d´Hebron University Hospital, Vall d´Hebron Institute of Oncology, Barcelona, Spain., Punie K; Department of General Medical Oncology and Multidisciplinary Breast Center, Leuven Cancer Institute, University Hospitals Leuven, Leuven, Belgium., Bajpai J; Department of Medical Oncology, Tata Memorial Centre, Homi Bhabha National Institute, Mumbai, India., Ignatiadis M; Breast Medical Oncology Clinic, Institut Jules Bordet, Université Libre de Bruxelles (ULB), Hôpital Universitaire de Bruxelles (HUB), Brussels, Belgium., Moore HCF; Department of Hematology and Medical Oncology, Cleveland Clinic Taussig Cancer Institute, Cleveland, Ohio., Phillips KA; Department of Medical Oncology, Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia.; Sir Peter MacCallum Department of Oncology, The University of Melbourne, Melbourne, Victoria, Australia.; Centre for Epidemiology and Biostatistics, School of Population and Global Health, The University of Melbourne, Melbourne, Victoria, Australia., Toss A; Department of Oncology and Haematology, Azienda Ospedaliero-Universitaria di Modena, Modena, Italy.; Department of Medical and Surgical Sciences, University of Modena and Reggio Emilia, Modena, Italy., Rousset-Jablonski C; Department of Surgery, Leon Berard Cancer Center, Lyon, France., Peccatori FA; Gynecologic Oncology Department, European Institute of Oncology (IRCCS), Milan, Italy., Renaud T; Cancer Genetics Unit, Bergonie Institute, Bordeaux, France., Ferrari A; Hereditary Breast and Ovarian Cancer Unit and General Surgery 3-Senology, Surgical Department, Fondazione IRCCS Policlinico San Matteo, and University of Pavia, Pavia, Italy., Paluch-Shimon S; Breast Oncology Unit, Sharett Institute of Oncology, Hadassah University Hospital, and Faculty of Medicine, Hebrew University, Jerusalem, Israel., Fruscio R; UO Gynecology, Department of Medicine and Surgery, University of Milan-Bicocca, IRCCS San Gerardo dei Tintori, Monza, Italy., Cui W; Department of Medical Oncology, Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia.; Sir Peter MacCallum Department of Oncology, The University of Melbourne, Melbourne, Victoria, Australia., Wong SM; Stroll Cancer Prevention Centre, Jewish General Hospital, and McGill University Medical School, Montreal, Quebec, Canada., Vernieri C; Department of Medical Oncology, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy.; IFOM ETS, AIRC Institute of Molecular Oncology, Milan, Italy., Ruddy KJ; Department of Oncology, Mayo Clinic College of Medicine, Rochester, Minnesota., Dieci MV; Dipartimento di Scienze Chirurgiche, Oncologiche, e Gastroenterologiche, Università di Padova, Padova, Italy.; Oncologia 2, Istituto Oncologico Veneto IOV-IRCCS, Padova, Italy., Matikas A; Department of Oncology/Pathology, Karolinska Institute, and Breast Center, Karolinska University Hospital, Stockholm, Sweden., Rozenblit M; Department of Medical Oncology, Smilow Cancer Hospital at Yale New Haven, New Haven, Connecticut., Villarreal-Garza C; Breast Cancer Center, Hospital Zambrano Hellion-TecSalud, Tecnologico de Monterrey, Monterrey, Mexico., De Marchis L; Department of Radiological, Oncological, and Pathological Sciences, Sapienza University of Rome, Rome, Italy.; Division of Oncology, Department of Hematology, Oncology, and Dermatology, Umberto 1 University Hospital, Rome, Italy., Del Mastro L; Department of Internal Medicine and Medical Specialties (DIMI), School of Medicine, University of Genova, Genova, Italy.; Department of Medical Oncology, U. O. Clinica di Oncologia Medica, IRCCS Ospedale Policlinico San Martino, Genova, Italy., Puglisi F; Department of Medical Oncology, Centro di Riferimento Oncologico di Avano (CRO) IRCCS, Aviano, Italy.; Department of Medicine, University of Udine, Udine, Italy., Del Pilar Estevez-Diz M; Department of Radiology and Oncology, Instituto do Câncer do Estado de São Paulo, Faculdade de Medicina da Universidade de São Paulo, São Paulo, Brazil., Rodriguez-Wallberg KA; Department of Oncology-Pathology, Laboratory of Translational Fertility Preservation, Karolinska Institute, Stockholm, Sweden.; Department of Reproductive Medicine, Karolinska University Hospital, Stockholm, Sweden., Mrinakova B; First Department of Oncology, Comenius University and St Elisabeth Cancer Institute, Bratislava, Slovakia., Meister S; Department of Obstetrics and Gynecology, Ludwig Maximilian University (LMU) Hospital, LMU Munich, Germany., Livraghi L; Department of Medical Oncology, Azienda Ospedaliera Papa Giovanni XXIII, Bergamo, Italy.; Department of Medical Oncology, Hospital of Prato, Azienda USL Toscana Centro, Italy., Clatot F; Department of Medical Oncology, Centre Henri Becquerel, Rouen, France., Yerushalmi R; Department of Medical Oncology, Davidoff Center, Rabin Medical Center, Petah Tikva, Tel Aviv University, Tel Aviv, Israel., De Angelis C; Department of Medical Oncology, University of Naples Federico II, Napoli, Italy., Sánchez-Bayona R; Department of Medical Oncology, Hospital Universitario 12 de Octubre, Madrid, Spain., Meattini I; Department of Experimental and Clinical Biomedical Sciences M. Serio, University of Florence, and Radiation Oncology Unit, Oncology Department, Florence University Hospital, Florence, Italy., Cichowska-Cwalinska N; Department of Oncology and Radiotherapy, Medical University of Gdańsk, Gdańsk, Poland.; Early Phase Clinical Trials Centre, Medical University of Gdańsk, Gdańsk, Poland., Berlière M; Department of Medical Oncology and Breast Surgery, Cliniques Universitaires Saint Luc, Université Catholique de Louvain (UCL), Brussels, Belgium., Salama M; Oncofertility Consortium and Department of Obstetrics, Gynecology, and Reproductive Biology, Michigan State University, East Lansing., De Giorgi U; Department of Medical Oncology, IRCCS Istituto Romagnolo per lo Studio dei Tumori Dino Amadori, Meldola, Italy., Sonnenblick A; Oncology Division, Tel Aviv Sourasky Medical Center, Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel., Chiodi C; Cancer Survivorship Program-Molecular Predicitors and New Targets in Oncology, INSERM Unit 981, Gustave Roussy, Villejuif, France., Lee YJ; Division of Breast Surgery, Department of Surgery, Asan Medical Center, University of Ulsan College of Medicine, Seoul, South Korea., Maria C; Department of Medical Oncology, Universite Paris Cité, Institut Curie, Paris, France., Azim HA Jr; Breast Cancer Center, Hospital Zambrano Hellion-TecSalud, Tecnologico de Monterrey, Monterrey, Mexico.; Cairo Oncology Center, Cairo, Egypt., Boni L; U. O. Epidemiologia Clinica, IRCCS Ospedale Policlinico San Martino, Genova, Italy., Partridge AH; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts.

مؤلفون مشاركون: BRCA BCY Collaboration

المصدر: JAMA [JAMA] 2024 Jan 02; Vol. 331 (1), pp. 49-59.

نوع المنشور: Journal Article; Multicenter Study; Research Support, N.I.H., Extramural; Research Support, U.S. Gov't, P.H.S.

بيانات الدورية: Publisher: American Medical Association Country of Publication: United States NLM ID: 7501160 Publication Model: Print Cited Medium: Internet ISSN: 1538-3598 (Electronic) Linking ISSN: 00987484 NLM ISO Abbreviation: JAMA Subsets: MEDLINE

مواضيع طبية MeSH: Breast Neoplasms*/genetics , Breast Neoplasms*/mortality , Genes, BRCA2* , Genes, BRCA1* , Pregnancy Outcome* , Pregnancy Complications, Neoplastic*/genetics , Pregnancy Complications, Neoplastic*/mortality, Adult ; Female ; Humans ; Pregnancy ; Disease-Free Survival ; Germ-Line Mutation ; Retrospective Studies ; Internationality

المؤلفون: D'Onofrio R; Division of Medical Oncology, Department of Medical and Surgical Sciences for Children and Adults, University Hospital of Modena, 41125 Modena, Italy Gruppo Oncologico Italiano per la Ricerca Clinica (GOIRC), Parma, Italy., Sperduti I; Biostatistics Unit, IRCCS Regina Elena National Cancer Institute, Rome, Italy., Piacentini F; Division of Medical Oncology, Department of Medical and Surgical Sciences for Children and Adults, University Hospital of Modena, 41125 Modena, Italy Gruppo Oncologico Italiano per la Ricerca Clinica (GOIRC), Parma, Italy., Barbolini M; Division of Medical Oncology, Department of Medical and Surgical Sciences for Children and Adults, University Hospital of Modena, 41125 Modena, Italy Gruppo Oncologico Italiano per la Ricerca Clinica (GOIRC), Parma, Italy., Omarini C; Division of Medical Oncology, Department of Oncology and Hematology, University Hospital of Modena, Modena, Italy, Gruppo Oncologico Italiano per la Ricerca Clinica (GOIRC), Parma, Italy., Toss A; Division of Medical Oncology, Department of Medical and Surgical Sciences for Children and Adults, University Hospital of Modena, 41125 Modena, Italy Gruppo Oncologico Italiano per la Ricerca Clinica (GOIRC), Parma, Italy., Cortesi L; Division of Medical Oncology, Department of Oncology and Hematology, University Hospital of Modena, Modena, Italy, Gruppo Oncologico Italiano per la Ricerca Clinica (GOIRC), Parma, Italy., Barbieri E; Division of Medical Oncology, Department of Oncology and Hematology, University Hospital of Modena, Modena, Italy, Gruppo Oncologico Italiano per la Ricerca Clinica (GOIRC), Parma, Italy., Canino F; Division of Medical Oncology, Department of Medical and Surgical Sciences for Children and Adults, University Hospital of Modena, 41125 Modena, Italy Gruppo Oncologico Italiano per la Ricerca Clinica (GOIRC), Parma, Italy., Dominici M; Division of Medical Oncology, Department of Medical and Surgical Sciences for Children and Adults, University Hospital of Modena, Modena, Italy., Moscetti L; Division of Medical Oncology, Department of Oncology and Hematology, University Hospital of Modena, Modena, Italy, Gruppo Oncologico Italiano per la Ricerca Clinica (GOIRC), Parma, Italy. Electronic address: moscetti.luca@aou.mo.it.

المصدر: Clinical breast cancer [Clin Breast Cancer] 2023 Dec; Vol. 23 (8), pp. e534-e541. Date of Electronic Publication: 2023 Sep 09.

نوع المنشور: Meta-Analysis; Journal Article; Review

بيانات الدورية: Publisher: Elsevier Country of Publication: United States NLM ID: 100898731 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1938-0666 (Electronic) Linking ISSN: 15268209 NLM ISO Abbreviation: Clin Breast Cancer Subsets: MEDLINE

مواضيع طبية MeSH: Breast Neoplasms*/drug therapy , Breast Neoplasms*/chemically induced , Thromboembolism*/chemically induced, Humans ; Female ; Incidence ; Aromatase Inhibitors/adverse effects ; Cyclin-Dependent Kinase 4 ; Cyclin-Dependent Kinase 6

المؤلفون: Gori S; Medical Oncology Unit, IRCCS Sacro Cuore Don Calabria, 37024 Negrar di Valpolicella, Italy., Fabi A; Precision Medicine Unit in Senology, Fondazione Policlinico Universitario A. Gemelli IRCCS, 00168 Rome, Italy., Angiolini C; Breast Unit and Multidisciplinary Oncology Group, Department of Breast Oncology, AOU Careggi, 50134 Florence, Italy., Turazza M; Medical Oncology Unit, IRCCS Sacro Cuore Don Calabria, 37024 Negrar di Valpolicella, Italy., Salvini P; Oncology, Humanitas Gavazzeni, 24125 Bergamo, Italy.; Oncological Medicine-Policlinico Ponte S Pietro di Istituti Ospedalieri Bergamaschi, 24036 Ponte San Pietro, Italy., Ferretti G; Division of Medical Oncology 1, IRCCS Regina Elena National Cancer Institute, 00144 Rome, Italy., Cretella E; Oncology-Azienda Sanitaria dell'Alto Adige, 39100 Bolzano, Italy., Gianni L; Oncology-AUSL Romagna Rimini, 47900 Rimini, Italy., Bighin C; Oncology-IRCCS AOU San Martino IST, 16132 Genova, Italy., Toss A; Department of Oncology and Hematology, Azienda Ospedaliero-Universitaria di Modena, 41125 Modena, Italy.; Department of Medical and Surgical Sciences, University of Modena and Reggio Emilia, 41125 Modena, Italy., Zamagni C; Medical Oncology of Senology and Gynecology, IRCCS AOU Bologna, Policlinico Sant'Orsola, 40138 Bologna, Italy., Vici P; UOSD Sperimentazioni Fase IV, IRCCS Istituto Nazionale Tumori Regina Elena, 00144 Rome, Italy., De Rossi C; Oncology-Ospedale dell'Angelo Azienda ULSS 3 Serenissima, 30174 Venice, Italy., Russo A; Medical Oncology, AOU Policlinico P. Giaccone, 90127 Palermo, Italy., Bisagni G; Medical Oncology, Comprehensive Cancer Centre, AUSL-IRCCS di Reggio Emilia, 22100 Reggio Emilia, Italy., Frassoldati A; Clinical Oncology, Sant'Anna University Hospital, 44124 Ferrara, Italy., Borgato L; Department of Oncology, San Bortolo General Hospital, Azienda ULSS8 Berica, 36100 Vicenza, Italy., Cariello A; Medical Oncology, AUSL Ravenna, 48100 Ravenna, Italy., Cappelletti C; Medical Oncology, Fano Hospital, 61032 Fano, Italy., Bordonaro R; Medical Oncology, ARNAS Garibaldi Hospital, 95124 Catania, Italy., Cinieri S; Medical Oncology, Antonio Perrino Hospital, 72100 Brindisi, Italy., Modena A; Medical Oncology Unit, IRCCS Sacro Cuore Don Calabria, 37024 Negrar di Valpolicella, Italy., Valerio M; Medical Oncology Unit, IRCCS Sacro Cuore Don Calabria, 37024 Negrar di Valpolicella, Italy., Alvisi MF; Laboratory of Methodology for Clinical Research, Department of Clinical Oncology, Istituto di Ricerche Farmacologiche Mario Negri IRCCS, Via Mario Negri 2, 20156 Milan, Italy., De Simone I; Laboratory of Methodology for Clinical Research, Department of Clinical Oncology, Istituto di Ricerche Farmacologiche Mario Negri IRCCS, Via Mario Negri 2, 20156 Milan, Italy., Galli F; Laboratory of Methodology for Clinical Research, Department of Clinical Oncology, Istituto di Ricerche Farmacologiche Mario Negri IRCCS, Via Mario Negri 2, 20156 Milan, Italy., Rulli E; Laboratory of Methodology for Clinical Research, Department of Clinical Oncology, Istituto di Ricerche Farmacologiche Mario Negri IRCCS, Via Mario Negri 2, 20156 Milan, Italy., Santoni A; Laboratory of Methodology for Clinical Research, Department of Clinical Oncology, Istituto di Ricerche Farmacologiche Mario Negri IRCCS, Via Mario Negri 2, 20156 Milan, Italy., Nicolis F; Medical Direction, IRCCS Sacro Cuore Don Calabria, 37024 Negrar di Valpolicella, Italy.

المصدر: Cancers [Cancers (Basel)] 2023 Oct 04; Vol. 15 (19). Date of Electronic Publication: 2023 Oct 04.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: MDPI Country of Publication: Switzerland NLM ID: 101526829 Publication Model: Electronic Cited Medium: Print ISSN: 2072-6694 (Print) Linking ISSN: 20726694 NLM ISO Abbreviation: Cancers (Basel) Subsets: PubMed not MEDLINE

المؤلفون: Quarello P; Pediatric Onco-Hematology, Stem Cell Transplantation and Cellular Therapy Division, Regina Margherita Children's Hospital, Torino, Italy.; Department of Sciences of Public Health and Pediatrics, University of Turin, Turin, Italy., Toss A; Department of Oncology and Hematology, Azienda Ospedaliero-Universitaria di Modena, Modena, Italy.; Department of Medical and Surgical Sciences, University of Modena and Reggio Emilia, Modena, Italy., Berchialla P; Department of Clinical and Biological Sciences, University of Torino, Torino, Italy., Mascarin M; AYA Oncology and Department of Radiation Oncology, Centro di Riferimento Oncologico, Aviano, Italy., Lambertini M; Departament of Medical Oncology, U.O. Clinica di Oncologia Medica, IRCCS Ospedale Policlinico San Martino, Genova, Italy.; Department of Internal Medicine and Medical Specialties (DiMI), School of Medicine, University of Genova, Genova, Italy., Canesi M; Department of Pediatrics, University of Milano-Bicocca, Fondazione IRCCS San Gerardo dei Tintori, Monza, Italy., Maria Milano G; Department of Pediatric Onco-Hematology and Cell and Gene Therapy, Bambino Gesù Children Hospital, Roma, Italy., Incorvaia L; Department of Surgical, Oncological and Oral Sciences Section of Medical Oncology University of Palermo, Palermo, Italy., Luigi Banna G; Portsmouth Hospitals University NHS Trust, Portsmouth, PO6 3LY, UK., Peccatori F; Gynecologic Oncology Department, European Institute of Oncology IRCCS, Milano, Italy., Ferrari A; Pediatric Oncology Unit, Fondazione IRCCS Istituto Nazionale dei Tumori, Milano, Italy.

المصدر: The oncologist [Oncologist] 2023 Oct 03; Vol. 28 (10), pp. e884-e890.

نوع المنشور: Journal Article; Research Support, Non-U.S. Gov't

بيانات الدورية: Publisher: Oxford University Press Country of Publication: England NLM ID: 9607837 Publication Model: Print Cited Medium: Internet ISSN: 1549-490X (Electronic) Linking ISSN: 10837159 NLM ISO Abbreviation: Oncologist Subsets: MEDLINE

مواضيع طبية MeSH: Sexual Health* , Neoplasms*/complications , Neoplasms*/therapy, Child ; Humans ; Adolescent ; Young Adult ; Delivery of Health Care ; Health Personnel ; Italy ; Communication